These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 26916641)

  • 1. In Vitro Metabolic Stability and Permeability of Gymnemagenin and Its In Vivo Pharmacokinetic Correlation in Rats - A Pilot Study.
    Bera R; Kundu A; Sen T; Adhikari D; Karmakar S
    Planta Med; 2016 Apr; 82(6):544-50. PubMed ID: 26916641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of in vitro Caco-2 permeability and liver microsomal half-life screens in discovering BMS-488043, a novel HIV-1 attachment inhibitor with improved pharmacokinetic properties.
    Yang Z; Zadjura LM; Marino AM; D'Arienzo CJ; Malinowski J; Gesenberg C; Lin PF; Colonno RJ; Wang T; Kadow JF; Meanwell NA; Hansel SB
    J Pharm Sci; 2010 Apr; 99(4):2135-52. PubMed ID: 19780144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of gymnemagenin in rat plasma using high-performance liquid chromatography-tandem mass spectrometry: application to pharmacokinetics after oral administration of Gymnema sylvestre extract.
    Kamble B; Gupta A; Patil D; Khatal L; Janrao S; Moothedath I; Duraiswamy B
    Biomed Chromatogr; 2013 May; 27(5):669-75. PubMed ID: 23225496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro phase I cytochrome P450 metabolism, permeability and pharmacokinetics of SB639, a novel histone deacetylase inhibitor in preclinical species.
    Venkatesh PR; Goh E; Zeng P; New LS; Xin L; Pasha MK; Sangthongpitag K; Yeo P; Kantharaj E
    Biol Pharm Bull; 2007 May; 30(5):1021-4. PubMed ID: 17473456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro drug metabolism and pharmacokinetics of a novel thiazolidinedione derivative, a potential anticancer compound.
    S S; Vuppu S
    J Pharm Biomed Anal; 2020 Feb; 179():113000. PubMed ID: 31787460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myrtucommulone from Myrtus communis: metabolism, permeability, and systemic exposure in rats.
    Gerbeth K; Hüsch J; Meins J; Rossi A; Sautebin L; Wiechmann K; Werz O; Skarke C; Barrett JS; Schubert-Zsilavecz M; Abdel-Tawab M
    Planta Med; 2012 Dec; 78(18):1932-8. PubMed ID: 23150076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability of caffeic acid in rats and its absorption properties in the Caco-2 cell model.
    Wang SJ; Zeng J; Yang BK; Zhong YM
    Pharm Biol; 2014 Sep; 52(9):1150-7. PubMed ID: 24635458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical comprehensive physicochemical and pharmacokinetic profiling of novel nitroimidazole derivative IIIM-019 - A potential oral treatment for tuberculosis.
    Kour G; Kumar A; Singh PP; Sharma S; Bhagat A; Vishwakarma RA; Ahmed Z
    Pulm Pharmacol Ther; 2016 Oct; 40():44-51. PubMed ID: 27457685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL.
    Kamath AV; Wang J; Lee FY; Marathe PH
    Cancer Chemother Pharmacol; 2008 Mar; 61(3):365-76. PubMed ID: 17429625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biopharmaceutical and pharmacokinetic characterization of matrine as determined by a sensitive and robust UPLC-MS/MS method.
    Yang Z; Gao S; Yin T; Kulkarni KH; Teng Y; You M; Hu M
    J Pharm Biomed Anal; 2010 Apr; 51(5):1120-7. PubMed ID: 20034755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of verapamil on the pharmacokinetics of curculigoside in rats.
    Wang K; Zhao J; Lang J
    Pharm Biol; 2016 Dec; 54(12):3001-3008. PubMed ID: 27328778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of pharmacokinetic and metabolic profiling among gossypol, apogossypol and apogossypol hexaacetate.
    Jia L; Coward LC; Kerstner-Wood CD; Cork RL; Gorman GS; Noker PE; Kitada S; Pellecchia M; Reed JC
    Cancer Chemother Pharmacol; 2008 Jan; 61(1):63-73. PubMed ID: 17356822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A strategy to reduce biliary clearance in early drug discovery.
    Rioux N; Bellavance E; Poirier H; Dupuis M; Garneau M; Ribadeneira MD; Duan J
    J Pharmacol Toxicol Methods; 2013; 68(3):346-8. PubMed ID: 23518065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biopharmaceutical and pharmacokinetic characterization of asiatic acid in Centella asiatica as determined by a sensitive and robust HPLC-MS method.
    Yuan Y; Zhang H; Sun F; Sun S; Zhu Z; Chai Y
    J Ethnopharmacol; 2015 Apr; 163():31-8. PubMed ID: 25596352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of
    K Pinjari MJS; Somani R; Gilhotra RM
    Indian J Pharmacol; 2017; 49(4):297-303. PubMed ID: 29326490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elucidation of pharmacokinetics of novel DNA ligase I inhibitor, S012-1332 in rats: Integration of in vitro and in vivo findings.
    Riyazuddin M; Valicherla GR; Husain A; Hussain MK; Shukla M; Katekar R; Gupta AP; Singh P; Banerjee D; Hajela K; Gayen JR
    J Pharm Biomed Anal; 2019 Jan; 162():205-214. PubMed ID: 30265980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Gymnema sylvestre extract on the pharmacokinetics and pharmacodynamics of glimepiride in streptozotocin induced diabetic rats.
    Kamble B; Gupta A; Moothedath I; Khatal L; Janrao S; Jadhav A; Duraiswamy B
    Chem Biol Interact; 2016 Feb; 245():30-8. PubMed ID: 26721197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical pharmacokinetics of a novel HIV-1 attachment inhibitor BMS-378806 and prediction of its human pharmacokinetics.
    Yang Z; Zadjura L; D'Arienzo C; Marino A; Santone K; Klunk L; Greene D; Lin PF; Colonno R; Wang T; Meanwell N; Hansel S
    Biopharm Drug Dispos; 2005 Dec; 26(9):387-402. PubMed ID: 16142720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of in vitro metabolic stability, plasma protein binding, and pharmacokinetics of E- and Z-guggulsterone in rat.
    Chhonker YS; Chandasana H; Mukkavilli R; Prasad YD; Laxman TS; Vangala S; Bhatta RS
    Drug Test Anal; 2016 Sep; 8(9):966-75. PubMed ID: 26608935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biopharmaceutics and Pharmacokinetics of Timosaponin A-III by a Sensitive HPLC-MS/MS Method: Low Bioavailability Resulting from Poor Permeability and Solubility.
    Wang HQ; Gong XM; Lan F; Zhang YH; Xia JE; Zhang H; Guo JL; Liu M
    Curr Pharm Biotechnol; 2021; 22(5):672-681. PubMed ID: 32634081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.